Meena Subramanyam

Clinical development of biosimilars: an evolving landscape.

Meena Subramanyam, M. Subramanyam, 2013, Bioanalysis.

Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.

Lakshmi Amaravadi, Alvydas Mikulskis, Meena Subramanyam, 2011, Journal of immunological methods.

Increased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients.

William S Hancock, Meena Subramanyam, Eric Wakshull, 2008, Clinical chemistry.

Translational biomarkers: from discovery and development to clinical practice.

Meena Subramanyam, M. Subramanyam, Jaya Goyal, 2016, Drug discovery today. Technologies.

A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution.

Lakshmi Amaravadi, Meena Subramanyam, M. Subramanyam, 2010, Journal of immunological methods.

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Meena Subramanyam, A. Sandrock, C. Hotermans, 2012, The New England journal of medicine.

Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics.

Viswanath Devanarayan, An Song, Susan Kirshner, 2011, Journal of pharmaceutical and biomedical analysis.